Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion

Cardiovascular Research

Volumn 33, Issue 2, 1997, Pages 469-477

  Vogt, Achim M ^a   Htun, Patrik ^a   Kluge, Angelika ^a   Zimmermann, René ^a   Schaper, Wolfgang ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

insulin; insulin like growth factor II; myocardial infarction; myocardial protection; preconditioning

Indexed keywords

LAVENDUSTIN A; RECOMBINANT SOMATOMEDIN B; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CORONARY DISEASE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR II; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; PHENOLS; PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; SWINE;

EID: 0031015780     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00212-X     Document Type: Article

References (46)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Schaper W, Zimmermann R, Kluge A, et al. Patterns of myocardial gene expression after cycles of brief coronary occlusion and reperfusion. Ann NY Acad Sci 1994;723:284-291.
3. Kluge A, Zimmermann R, Münkel B, Verdouw P, Schaper J, Schaper W. Insulin-like growth factor II is an experimental stress inducible gene in a porcine model of brief coronary occlusions. Cardiovasc Res 1995;29:708-716.
4. Cochik WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-153.
5. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591-614.
6. Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab 1994;14:237-242.
7. Zhu CZ, Auer RN. Centrally administered insulin and IGF-1 in transient forebrain ischemia in fasted rats. Neurol Res 1994;16:116-120.
8. Strong AJ, Fairfield JE, Monteiro E, et al. Insulin protects cognitive function in experimental stroke. J Neurol Neurosurg Psychiatry 1990;53:847-53.
9. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995;82:262-268.
10. Aoki M, Abe K, Kawagoe J, Nakamura S, Kogure K. The preconditioned hippocampus accelerated HSP70 heat shock gene expression following transient ischemia in the gerbil. Neurosci Lett 1993;155:7-10.
11. Aoki M, Abe K, Kawagoe J, Nakamura S, Kogure K. Acceleration of HSP70 and HSC70 heat shock gene expression following transient ischemia in the preconditioned gerbil hippocampus. J Cereb Blood Flow Metab 1993;13:781-788.
12. Liu Y, Kato H, Nakata N, Kogure K. Temporal profile of heat shock protein-70 synthesis in ischemic tolerance induced by preconditioning ischemia in rat hippocampus. Neuroscience 1993;56:921-927.
13. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994;168:221-224.
14. Kato H, Liu Y, Kogure K, Kato K. Induction of 27-kDa beat shock protein following cerebral ischemia in a rat model of ischemic tolerance. Brain Res 1994;634:235-244.
15. Burguera B, Elton CW, Tapscott EB, Pories WJ, Dimarchi R, Sakano K. Stimulation of glucose uptake by insulin-like growth factor II/mannose 6-phosphate receptor. Biochem J 1994;300:781-785.
16. Bevan SJ, Parry-Billings M, Opara E, Liu CT, Dunger DB, Newsholme EA. The effect of insulin-like growth factor II on glucose uptake and metabolism in the rat skeletal muscle in vitro. Biochem J 1992;286:561-565.
17. Tonnessen T, Giaid A, Saleh D, Neass PA, Yanagisawa M, Chrisv tensen G. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 1995;76:767-772.
18. Draznin B, Chang L, Leitner JW, Takata Y, Olefsky JM. Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors. J Biol Chem 1993;268:19998-20001.
19. O'Dell TJ, Kandel ER, Grant SG. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 1991;353:558-560.
20. Hellenius M, Brismar K, Gerglund B, De Faire U. Effects on glucose tolerance insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle aged men. J Intern Med 1995;238:121-130.
21. Sack S, Mohri M, Arras M, Schwarz ER, Schaper W. Ischaemic preconditioning - time course of renewal in the pig. Cardiovasc Res 1993;27:551-555.
22. Lewitt MS. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 1994;23:3-15.
23. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation 1994;90:3486(Abstract).
24. Vogt AM, Htun P, Arras M, Elsässer A, Podzuweit T, Schaper W. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol 1996;91:389-400.
25. Burke TJ. Protein-tyrosine kinases: potential targets for anticancer drug development. Stem Cells Dayt 1994;12:1-6.
26. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985;47:443-467.
27. Cohik W, Clemmons D. The insulin-like growth factors. Annu Rev Physiol 1985;55:131-153.
28. Herington AC. Insulin-like growth factors: biochemistry and physiology. Baillieres Clin Endocrinol Metab 1991;5:531-551.
29. Kluge A, Zimmermann R, Münkel B, et al. Insulin-Like Growth Factor II (IGF-II) ist ein Stress-Gen und ein trophischer Faktor im Herzmuskel des Schweines. Z Kardiol 1993;82(Suppl 1):521(Abstract).
30. Kluge A, Zimmermann R, Münkel B, Verdouw PD, Schaper J, Schaper W. Localization of insulin-like growth factor II (IGF-II), a stress-response gene, in ischemic porcine heart. J Mol Cell Cardiol 1993;25(suppl1):III-P-4(Abstract).
31. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-1142.
32. Kornfeld S. Structure and function of the mannose 6-phosphate/insulin like growth factor II receptors. Annu Rev Biochem 1992;61:307-330.
33. Kluge A, Zimmermann R, Weihrauch D, et al. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc Res 1996;in press.
34. Roth RA, Kiess W. Insulin-like growth factor: recent developments and new methodologies. Growth Regul 1994;1:31-38.
35. Apstein C, Gravino F, Haudenschild C. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Circ Res 1983;52:515-526.
36. Opie L, Bruyneel K, Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in baboon. Circulation 1975;52:49-57.
37. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971;43:67-82.
38. Rahimtoola SH. Chronic myocardial hibernation. Circulation 1994;89:1907.
39. Camici P, Ferranini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-238.
40. Thornton J, Striplin S, Liu GS, et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990;259:H1822-H1825.
41. Strasser R, Arras M, Elsässer A, et al. Preconditioning of porcine myocardium: How much ischemia is required for induction? What is its duration? Is a renewal effect possible? Circulation 1994;90(part 2):579(Abstract).
42. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542-550.
43. Law WR, McLane MP. Adenosine enhances myocardial glucose uptake only in the presence of insulin. Metabolism 1991;40:947-952.
44. Law W, McLane M, Raymond R. Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes 1988;37:842-845.
45. 6-(L-2-phenylisoprophyl) adenosine. Circ Res 1991;69:791-799.
46. 2+-induced ventricular tachycardia in the intact pig heart. Basic Res Cardiol 1980;75:772-779.